Health care delivery is always in flux, but treatment advances have introduced new variables into the health care continuum that were unthinkable even a decade ago.
Journal of Clinical Pathways spoke with Winston Wong, PharmD, editor-in-chief about the role of clinical pathways and value-based care in health care reform.
The value of different gene therapies is likely to vary based on both potential for clinical benefit and what they are able to demonstrate in registration trials.
Benjamin Djulbegovic, MD, PhD, speaks about the need for effective entry points to discuss palliative care for patients with cancer.
Clinical Pathways in Community Oncology: Assessing the Work of the American Society of Clinical Oncology Task Force on Clinical Pathways
Journal of Clinical Pathways spoke with Robin Zon, MD, FACP, FASCO, chair of ASCO’s Task Force on Clinical Pathways and medical oncologist at Michiana Hematology Oncology, Mishawaka, IN.
Amid the recent political changes in the United States, there has been plentiful discussion about what the future of health care will look like.
Clinical pathways for multiple sclerosis should address concurrent health problems associated with the condition.
The increase of insurers investing in quality initiatives has driven healthy competition to develop strategic models to ensure better outcomes and engagement.
As we bring a close to 2016, the first full year of publication of Journal of Clinical Pathways (JCP), it is a good opportunity to reflect on how the role of clinical pathways in the health care landscape has grown and evolved.
The author highlights the potential benefits of prescribing specific sites of care in clinical pathways.